Treatment of hyperbilirubinemia with blood purification in China

World J Gastroenterol. 2006 Dec 14;12(46):7467-71. doi: 10.3748/wjg.v12.i46.7467.

Abstract

The incidence of hyperbilirubinemia is high clinically, which is difficult to cure by medication, surgery or interventional therapies. Non-bioartificial liver is the main alternative in the blood purification for hyperbilirubinemia, which includes plasma exchange, hemoperfusion, hemodialysis, molecular adsorbent recycling system and so on. The research results and clinical experiences in China show that these methods are effective in lowering high levels of bilirubin with fewer side effects. The hyperbilirubinemias of different causes, with different complications or accompanying different diseases can be treated by different methods. Bioartificial liver, hybrid artificial liver support system and adsorbent membrane material have also been studied and their development in reducing hyperbilirubinemias has been achieved. This article gives a brief overview on the actuality and research improvement in blood purification for hyperbilirubinemia in China.

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Bilirubin / blood
  • Bilirubin / isolation & purification
  • China
  • Hemoperfusion
  • Humans
  • Hyperbilirubinemia / blood
  • Hyperbilirubinemia / therapy*
  • Liver, Artificial
  • Plasma Exchange
  • Renal Dialysis
  • Sorption Detoxification / methods

Substances

  • Bilirubin